![Walker A. Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Walker A. Long
Direktor/Vorstandsmitglied bei
BioMarck Pharmaceuticals Ltd.
Profil
Dr. Walker A. Long, MD, is Chief Medical Officer & VP-Drug Development at Biolex Therapeutics, Inc. He is on the Board of Directors at BioMarck Pharmaceuticals Ltd.
Dr. Long was previously employed as Vice President-Clinical Development by AtheroGenics, Inc., Senior Vice President-Project Operations by Cato Research Ltd, a Faculty Member by University of North Carolina at Chapel Hill, and a Principal by Wellcome Research Laboratories.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from the University of North Carolina at Chapel Hill.
Aktive Positionen von Walker A. Long
| Unternehmen | Position | Beginn |
|---|---|---|
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Walker A. Long
| Unternehmen | Position | Ende |
|---|---|---|
Wellcome Research Laboratories | Corporate Officer/Principal | - |
The University of North Carolina at Asheville
 The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Walker A. Long
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Biolex Therapeutics, Inc.
Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Distribution Services |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Wellcome Research Laboratories | |
The University of North Carolina at Asheville
The University of North Carolina at Asheville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
